| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |